Usefulness of Intraosseous Anesthesia for Permanent Tooth Extraction Under GA in Pediatric Dental Treatment
NCT ID: NCT07108439
Last Updated: 2025-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
80 participants
INTERVENTIONAL
2025-08-14
2027-05-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Local Anaesthesia Technique on the Recovery After Dental Treatment in General Anaesthesia
NCT04156334
Childrens' Experiences of Pain in Conjunction With Tooth Extraction - a Grounded Theory Study
NCT04064853
Computer - Controlled Intraligamentary Local Anaesthesia In Extraction of Primary Molars
NCT04739735
Self-Reported Pain in Children Submitted to Single Infiltration of Articaine During Primary Molar Extraction
NCT05443009
Comparison of the Computer Controlled and Conventional Local Anesthesia Techniques in Primary Molar Extraction in Children Aged 5 to 9 Years Old
NCT06669039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Intra-osseous anesthesia consists of 3 major steps:
1. Limited superficial anesthesia of the mucosa at the level of the tooth to be treated/extracted
2. Perforation of the bone by means of a rotating needle movement
3. Injection of the local anesthetic directly into the bone The operator (AG) will administer the intra-osseous anesthesia just before the tooth(s) are extracted. The extractions will always be performed at the end of the dental treatment.
A permanent molar must be removed from the child and this will be done under general anesthesia. Previous scientific studies have shown that when the dentist also administers local anesthesia during general anesthesia for tooth removal, children suffer from side effects of the local anesthesia. These side effects include numbness and lip or cheek biting. This can make them extra agitated when waking up from general anesthesia.
This intra-osseous anesthesia technique only anesthetizes the tooth. As a result, the child should not experience the above-mentioned side effects or to a lesser extent. In this study,The investigators want to investigate this effect. The advantage of this technique is that the child is expected to need little or no painkillers after the operation compared to the current procedure.
On the day of the procedure, upon arrival at the hospital, three short questionnaires will be administered regarding anxiety and pain. One questionnaire is observational, for the other two he investigators ask a little cooperation from the patient. This concerns the FLACC (Face, Legs, Activity, Cry, Consolability), VAS (Visual Analogue Scale) and CFSS-DS (Children's Fear Survey Schedule - Dental Scale).
If the patient is randomly assigned to the group that will receive local anaesthetic, this will be administered intra-osseously with the Quicksleeper 5 just before the tooth(s) is/are removed. The local anaesthetic that will be used is articaine 4% with epinephrine 1/100,000, this is a standard local anaesthetic in dentistry, the good and efficient effect of which has long been demonstrated.
Group 1 will receive local anaesthesia intra-osseously and group 2 will not. There is no further distinction between the groups.
The time at which the local anaesthetic is administered and the time at which the procedure is over will be noted.
After the procedure, the same questionnaires will be administered at set times as before the procedure. The patient does not have to stay in the hospital longer than normal for these questionnaires. The FLACC will be administered after 10/30/60/120 min, the VAS when the patient is able to speak and after 120 min, the CFSS-DS after 120 min and the delirium flowchart is an observational measurement that will be performed 5 min after spontaneously opening the eyes. The day after the procedure, the parents/guardian will be asked to answer one more questionnaire of approximately 20 questions via a QR code received.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
It is a double blind study in which the operator knows whether she is giving intra-osseus anesthesia (articaine) or not, but the patient and the evaluator of the pre- and post- operative scales will not know if the patient got local anaesthesia or not.
SR has the excel file with the results of the block randomisation and key for blinding (pseudonymization).
Allocation concealment will be performed by with the sealed envelope technique.SR is independent of the study results. He has no access to the results of the patients.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intra osseous administration of local anesthesia during general anesthesia
Intra osseous administration of articain 4% 1/100 000 during general anesthesia for the extraction of a first permanent molar. The administration will be done with Quicksleeper 5.
Administration of intra-osseous local anesthesia before the extraction of a first permanent molar under general anesthesia
Intra osseous administration of articain 4% 1/100 000 during general anesthesia for the extraction of a first permanent molar. The administration will be done with Quicksleeper 5.
Control group
Normal procedure: no local anesthesia for the extraction of a first permanent molar during general anesthesia
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Administration of intra-osseous local anesthesia before the extraction of a first permanent molar under general anesthesia
Intra osseous administration of articain 4% 1/100 000 during general anesthesia for the extraction of a first permanent molar. The administration will be done with Quicksleeper 5.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children who are cooperative enough for pre- and post-operative measurements
* Children who are not allergic to components of local anaesthesia
* Children who need at least one extraction of a FPM
* Children without a hematological condition
* Children who haven't taken painkillers 48 hours before the procedure
* Patients who need a treatment under general anaesthesia (nasal intubation) due to polycaries/fear/anxiety.
* Able to obtain a written consent from the parent/guardian after explaining the full details of the treatment procedure and its possible outcomes
* Deviation in the pain relief protocol
* Parents/child don't speak Dutch
* Patients with missing data during the procedure/follow-up
Exclusion Criteria
* If a traumatic extraction is needed, this patient is excluded from the study
6 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chloƫ Sterkens
Role: PRINCIPAL_INVESTIGATOR
Equal Lifelong Oral Health for All Research Group, Paediatric Dentistry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ghent University Hospital
Ghent, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ONZ-2025-0166
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.